QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Horizon Therapeutics PublicCureVacBioMarin PharmaceuticalAlnylam PharmaceuticalsCatalent
SymbolNASDAQ:HZNPNASDAQ:CVACNASDAQ:BMRNNASDAQ:ALNYNYSE:CTLT
Price Information
Current Price$91.91$96.18$79.17$148.75$116.40
52 Week RangeBuyHoldBuyHoldBuy
MarketRank™
Overall Score2.40.61.91.61.5
Analysis Score2.51.13.32.21.4
Community Score3.32.03.13.32.4
Dividend Score0.00.00.00.00.0
Ownership Score1.70.01.71.71.7
Earnings & Valuation Score4.40.01.30.61.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyHoldBuy
Consensus Price Target$101.89$58.33$115.61$163.42$121.38
% Upside from Price Target10.86% upside-39.35% downside46.03% upside9.86% upside4.27% upside
Trade Information
Market Cap$20.06 billion$17.63 billion$14.37 billion$17.33 billion$19.36 billion
Beta1.15N/A0.711.471.5
Average Volume2,079,860812,5441,416,158814,1361,003,396
Sales & Book Value
Annual Revenue$1.30 billionN/A$1.70 billion$219.75 million$3.09 billion
Price / Sales15.84N/A8.4379.206.40
Cashflow$4.14 per shareN/A$0.61 per shareN/A$3.78 per share
Price / Cash22.22N/A130.22N/A30.82
Book Value$11.67 per shareN/A$17.38 per share$12.90 per share$18.71 per share
Price / Book7.88N/A4.5611.536.22
Profitability
Net Income$573.02 millionN/A$-23,850,000.00$-886,120,000.00$173 million
EPS$1.94N/A$0.07($8.11)$1.88
Trailing P/E Ratio25.110.0018.12N/A74.14
Forward P/E Ratio21.37N/A149.38N/A42.02
P/E Growth0.59N/A3.89N/A2.68
Net Margins43.55%N/A45.74%-222.19%9.25%
Return on Equity (ROE)25.66%N/A4.34%-65.96%14.20%
Return on Assets (ROA)14.19%N/A2.84%-31.38%4.83%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.26%N/A0.26%N/A0.97%
Current Ratio3.49%N/A3.20%5.32%2.56%
Quick Ratio3.39%N/A2.38%5.18%2.14%
Ownership Information
Institutional Ownership Percentage88.59%4.32%97.65%92.35%97.84%
Insider Ownership Percentage4.30%N/A2.15%3.50%1.00%
Miscellaneous
Employees1,2755003,0011,45314,000
Shares Outstanding224.05 million186.91 million181.53 million117.00 million170.23 million
Next Earnings Date5/5/2021 (Estimated)N/A5/5/2021 (Estimated)5/5/2021 (Estimated)5/4/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.